239 related articles for article (PubMed ID: 21359153)
1. Immunotherapy as a strategy for the treatment of non-small-cell lung cancer.
Holt GE; Podack ER; Raez LE
Therapy; 2011 Jan; 8(1):43-54. PubMed ID: 21359153
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome.
Shepherd FA; Douillard JY; Blumenschein GR
J Thorac Oncol; 2011 Oct; 6(10):1763-73. PubMed ID: 21876456
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in lung cancer.
Villaruz LC; Kalyan A; Zarour H; Socinski MA
Transl Lung Cancer Res; 2014 Feb; 3(1):2-14. PubMed ID: 25806276
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for lung cancer: ongoing clinical trials.
Declerck S; Vansteenkiste J
Future Oncol; 2014 Jan; 10(1):91-105. PubMed ID: 24143916
[TBL] [Abstract][Full Text] [Related]
5. Active immunotherapy for non-small-cell lung cancer: moving toward a reality.
Perez CA; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1599-605. PubMed ID: 21999133
[TBL] [Abstract][Full Text] [Related]
6. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
7. What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?
Reck M
Ann Oncol; 2012 Sep; 23 Suppl 8():viii28-34. PubMed ID: 22918925
[TBL] [Abstract][Full Text] [Related]
8. Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.
BioDrugs; 2003; 17(1):69-72. PubMed ID: 12534322
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for non-small-cell lung cancer.
Thomas A; Jakopovic M
Expert Opin Biol Ther; 2014 Aug; 14(8):1061-4. PubMed ID: 24878420
[TBL] [Abstract][Full Text] [Related]
10. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
11. Therapeutic vaccines in non-small cell lung cancer.
Socola F; Scherfenberg N; Raez LE
Immunotargets Ther; 2013; 2():115-24. PubMed ID: 27471692
[TBL] [Abstract][Full Text] [Related]
12. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
13. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
[TBL] [Abstract][Full Text] [Related]
14. Why has active immunotherapy not worked in lung cancer?
Thomas A; Giaccone G
Ann Oncol; 2015 Nov; 26(11):2213-20. PubMed ID: 26232492
[TBL] [Abstract][Full Text] [Related]
15. Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
Hall RD; Gray JE; Chiappori AA
Cancer Control; 2013 Jan; 20(1):22-31. PubMed ID: 23302904
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.
Anagnostou VK; Brahmer JR
Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
Vilariño N; Bruna J; Bosch-Barrera J; Valiente M; Nadal E
Cancer Treat Rev; 2020 Sep; 89():102067. PubMed ID: 32682248
[TBL] [Abstract][Full Text] [Related]
18. Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer.
Daly ME; Monjazeb AM; Kelly K
J Thorac Oncol; 2015 Dec; 10(12):1685-93. PubMed ID: 26484629
[TBL] [Abstract][Full Text] [Related]
19. Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy.
Rodríguez PC; Rodríguez G; González G; Lage A
MEDICC Rev; 2010; 12(1):17-23. PubMed ID: 20387330
[TBL] [Abstract][Full Text] [Related]
20. Immune modulation as a therapeutic strategy for non-small-cell lung cancer.
Holt GE; Disis ML
Clin Lung Cancer; 2008 Feb; 9 Suppl 1():S13-9. PubMed ID: 18540530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]